Search

everythinglearnresearchcommunity

for

Search:↓

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Platelet-rich plasma is beneficial in various plastic surgery applications, but more research is needed to standardize its use.

New treatments for male hair loss show promise but need more research for safety and effectiveness.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

New regenerative treatments for hair loss show promise but need more research for confirmation.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

New treatments for hair loss, including a compound called "ALRV5XR", platelet-rich plasma, and Adult Stem Cell-based therapy, are showing promise, but more trials are needed for confirmation.

New skin disease treatments using TDDS are improving but face challenges like side effects and high costs.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Customized medications made through compounding can be beneficial for various skin conditions but require careful regulation and collaboration between doctors and pharmacists.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Lasers are FDA-approved for permanent hair reduction, not removal, and more research is needed to improve treatments.

Risk analysis is important for safely adjusting pharmaceutical formulas while maintaining their quality and effectiveness.

A 60-year-old man with Cronkhite-Canada syndrome improved with treatment, but the condition has a high mortality rate and a risk of colorectal cancer.

Research on hair disorders has advanced, with promising future progress in understanding and treating these conditions.

We need better research to improve alopecia treatment and patient care.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Alopecia patients have a less active liver monoxygenase system, which can be treated with photochemotherapy and system inducers.

Spironolactone is more effective than finasteride in treating excessive hair growth in women.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Demodicosis is common and often missed, needing more recognition and treatment in skin care.

Type 2 diabetes, bacterial scalp infections, and tight hairstyles like braids and weaves are linked to a higher risk of a scarring hair loss condition in African American women.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

Men can report their own balding patterns well enough for large health studies.

Low iron levels are linked to more hair loss in non-menopausal women.

Finasteride use may lead to less alcohol consumption in men with lasting sexual side effects.

Niacin derivatives may increase hair fullness in women with hair loss.